Your browser doesn't support javascript.
loading
Safety of Intranasal Insulin in Type 2 Diabetes on Systemic Insulin: A Double-Blinded Placebo-Controlled Sub-Study of Memaid Trial.
Aponte Becerra, L; Galindo Mendez, B; Khan, F; Lioutas, V; Novak, P; Mantzoros, C S; Ngo, L H; Novak, V.
Afiliación
  • Aponte Becerra L; Department of Neurology, SAFE Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, USA.
  • Galindo Mendez B; Department of Internal Medicine, Jackson Memorial Hospital, University of Miami, Miami, FL, USA.
  • Khan F; Department of Neurology, SAFE Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, USA.
  • Lioutas V; Department of Neurology, SAFE Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, USA.
  • Novak P; Department of Neurology, SAFE Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, USA.
  • Mantzoros CS; Department of Neurology, Brigham and Women's Faulkner Hospital, Harvard Medical School, Boston, MA, USA.
  • Ngo LH; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA and Department of Medicine, Boston VA Healthcare System, Harvard Medical School, Boston, MA, USA.
  • Novak V; Department of Medicine, Beth Israel Deaconess Medical Center and School of Public Health, Harvard Medical School, Boston, MA, USA.
Arch Diabetes Obes ; 4(2): 403-415, 2022.
Article en En | MEDLINE | ID: mdl-35903156
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Arch Diabetes Obes Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Arch Diabetes Obes Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos